Skip to main content
H.R. 4106 116th Congress House

Responsibility in Drug Advertising Act of 2019

Official title: To amend the Federal Food, Drug, and Cosmetic Act to restrict direct-to-consumer drug advertising.

Introduced: July 30, 2019 Introduced by: Rosa L. DeLauro Democratic · Connecticut See on congress.gov
Health Drug safety, medical device, and laboratory regulationMarketing and advertisingPrescription drugs
Sign in to write a letter Sign in to watch
This bill died when the 116th Congress ended
It never became law before the 116th Congress (2019–2020) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Jul 31, 2019
Referred to the Subcommittee on Health.
Jul 30, 2019
Referred to the House Committee on Energy and Commerce.
Jul 30, 2019
Introduced in House
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Latest action July 31, 2019

Referred to the Subcommittee on Health.

 Plain-English summary Congressional Research Service

Responsibility in Drug Advertising Act of 2019

This bill prohibits direct-to-consumer advertising of a drug in the first three years after the drug's approval. The Food and Drug Administration may (1) waive the third year of this prohibition for a drug if direct-to-consumer advertising of the drug would have an affirmative value to public health, or (2) extend the prohibition if the drug has significant adverse health effects.
 Related & companion bills 2
  • S 3180 Identical bill Responsibility in Drug Advertising Act of 2020
  • HR 2452 Medicare for America Act of 2019
 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 2
 Cosponsors 2
All 2 Democratic 2
D
Pappas, Chris
New Hampshire · Aug 2, 2019
 D
Khanna, Ro
California · Jul 30, 2019
Cite this page click to expand
APA
U.S. Congress. (2026). H.R. 4106: Responsibility in Drug Advertising Act of 2019. 116th Congress. Open America. https://openamerica.io/bill/116-HR-4106/
MLA
"H.R. 4106: Responsibility in Drug Advertising Act of 2019." 116th Congress, 2026, Open America, https://openamerica.io/bill/116-HR-4106/.
Bluebook (legal)
H.R. 4106, 116th Cong. (2026), https://openamerica.io/bill/116-HR-4106/.
Markdown link
[H.R. 4106: Responsibility in Drug Advertising Act of 2019](https://openamerica.io/bill/116-HR-4106/)
Report a problem